Condition: Stroke, Acute Ischemic · Sponsor: Xinqiao Hospital of Chongqing
In patients with acute ischemic stroke secondary to large vessel occlusion, the role of intravenous adjunctive medications, such as tirofiban, or alteplase before endovascular thrombectomy has not been well investigated. This trial aim to evaluate the efficacy and safety of intravenous tirofiban versus alteplase for acute ischemic stroke patients with large vessel occlusion piror to endovascular thrombectomy.
This description comes directly from the study's public registry record.
Hongfei Sang, Doctor · +8613738132047 · sanghongfei1988@163.com
Zhongming Qiu, Doctor · +8613236599269 · qiuzhongmingdoctor@163.com
Always discuss trial participation with your own doctor first.
| Hangzhou First People's Hospital | Hangzhou, Zhejiang, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05728333